Calendar

Allstate has a confirmed Nov. 4 release and a recent +4.61% upward revision to quarterly EPS estimates, with consensus revenue implying 4.9% year-over-year growth. That creates a plausible but not clean surprise setup: consensus EPS still implies a steep year-over-year decline, the latest close was weak within its daily range, and no qualifying very recent volume surge was verified.

MetLife has a company-confirmed Nov. 4 report and third-party sources provide EPS and revenue consensus, but the checked sources did not establish positive estimate revisions, revenue upside revisions, or a qualifying recent price/volume setup. A pre-event preview also flags sensitivity to private-equity performance, leaving the surprise case too uncertain for this screen.

Aflac has a confirmed Nov. 4 report and consensus estimates, but the checked estimate history showed revenue revisions down 2.0% over three months and only marginally positive next-quarter EPS revisions; recent tape and volume signals were not established. A prior EPS miss and weak beat history further reduce the case for an underestimated upside surprise.

The checked sources give Q3 EPS consensus around $0.73–$0.74 and revenue consensus around $1.78B, while the prior quarter beat EPS consensus and management had issued a Q3 EPS range. No positive estimate-revision/whisper or revenue-upside signal, nor the required recent tape signals, was verified; the result is a thin-data reject rather than an investable setup.

The supplied calendar lists Nov. 4, but checked third-party sources disagree on the date and estimates; there is no substantiated positive EPS revision, revenue upside, or pre-event tape evidence to support a surprise setup.

MELI's Q2 primary-source results show strong commerce and fintech activity, and Oct 26 traded at unusually high volume with a close near the session high. However, the checked estimate source reports a 0.62% downward 30-day EPS revision; price fell sharply into Oct 26 and remains well below Oct 23, so the tape fails the required strength test despite the high-volume rebound.

The official earnings release was October 6, although the scheduled follow-up names October 13. Shares fell about 3.8% on October 6, from $45.46 to $43.72, then recovered only partly to the packet's $44.32 October 15 adjusted-close anchor; price action alone does not establish why investors sold. [Historical prices](https://chartexchange.com/symbol/nasdaq-vlgea/historical/) Verified post-print analyst revisions and consensus estimates remain unavailable, so missing coverage is not a positive signal. The prior neutral thesis remains broadly intact, but the Q4 cost pressure and fiscal 2027 investment plan sharpen monitoring priorities.

Company-reported results are positive, but the tape is mixed: Goldman rose more than 4% early on October 13, then closed about 0.2% lower, according to [AP](https://apnews.com/article/a2edaf9ec297fb75ff2a4e245063ec08). [Benzinga](https://www.benzinga.com/analyst-stock-ratings/price-target/26/10/62363583/these-analysts-lower-their-forecasts-on-goldman-sachs-after-q3-results) reported RBC and KBW target cuts on October 14. The 30-day news score is a qualitative estimate; zero social, options, short-interest and employee fields denote unavailable measurements, not neutral readings. No verified broad estimate-revision series or company Q4 numerical guidance is available in the checked evidence.

Mixed post-earnings tone: JNJ fell 5.7% on October 13 despite reported beats and a modest guidance lift, then gained 1.6% on October 14; the October 15 anchor was $253.28. Several post-print price targets were cut, although at least one was raised. The October 15 close remained below the pre-print level, so the initial negative reaction had not fully reversed. No reliable social, options-skew, short-interest or employee-sentiment measures were supplied; the zero placeholders above mean unavailable, not neutral readings. [Market reaction](https://www.kiplinger.com/investing/stocks/stocks-struggle-ahead-of-september-cpi-report-stock-market-today) [Benzinga revisions](https://www.benzinga.com/analyst-stock-ratings/price-target/26/10/62363208/these-analysts-cut-their-forecasts-on-johnson-and-johnson-after-q3-results) [October 15 close](https://www.marketscreener.com/quote/stock/JOHNSON-JOHNSON-4832/)

The October 14 close of $166.89 was 4.14% below the prior close, consistent with negative revenue-miss headlines despite the company raising parts of its full-year outlook. The -0.2 news score is a qualitative reading of the supplied headlines, not a measured feed. No verified post-print analyst revisions were available; the packet's $200.70 target lacks a count. Social, options, short-interest and employee-score zeros are unavailable-data placeholders, not measured neutral readings. The positive deterministic prior and strong primary earnings evidence justify monitoring for recovery, but not a bullish upgrade after the initial selloff. Price history: https://stockanalysis.com/stocks/stt/history/.

Merger coverage supplies a concrete company-specific narrative, but the scheduled earnings follow-up is not yet post-print. At 13:10 UTC on October 15, there is no confirmed fiscal fourth-quarter result, guidance change, analyst target revision, or post-release price move; zero-valued sentiment fields above denote unavailable measurements, not neutral observations. A pre-release Zacks item cited $0.84 EPS and $201.52 million revenue consensus, but those are expectations rather than reported results. [Zacks preview](https://finance.yahoo.com/markets/stocks/articles/wafd-wafd-earnings-expected-grow-130011856.html)

Company-reported results and wealth flows are positive, but early coverage describes shares slipping despite the beat ([Investing.com](https://www.investing.com/news/stock-market-news/why-is-morgan-stanley-stock-slipping-today-93CH-4948985)). Available third-party price reports conflict, so no precise post-release percentage move is asserted; the packet's $181.51 adjusted-close anchor is used for valuation. The T+1 analyst revision and target-change record is not yet established. Social, options, short-interest, and employee measures are unavailable rather than neutral.